Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-06-19.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Feb 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Maryland Inc | 19 Jun 2020 | Biologics | On file |
| AVEXIS | 8 Feb 2019 | Biologics | On file |
| Symbiosis Pharmaceutical Services Limited | 23 Feb 2018 | Biologics | On file |
| Oxford Biomedica (UK) Limited | 16 Feb 2018 | Biologics |
Sites inspected
Catalent Maryland IncHarmans, United States1 insp.
AVEXISLibertyville, United States1 insp.
Symbiosis Pharmaceutical Services LimitedStirling, United Kingdom1 insp.
Oxford Biomedica (UK) LimitedKidlington, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Wei Wang3 shared
Christine Harman2 shared
Wanda E Pagan1 shared
Bo Liang1 shared
Priscilla M Pastrana1 shared
Angela S Whatley1 shared
Deborah M Trout1 shared
Burnell M Henry1 shared
Full investigator report
Get the verbatim findings behind Andrew P Byrnes' inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site